Therefore, the proper study of Isthmin-1 in intestinal diseases, such as inflammatory bowel disease, Crohn’s disease, and various types of intestinal cancer, could open the possibility of using this molecule as both a diagnostic biomarker and a potential therapeutic tool. This evidence concerns the gene ISM1 and intestinal disorder.